You're currently viewing an old version of this dataset. To see the current version, click here.

Malawi Integrated HIV Program Report 2021 Q1

Program performance highlights by the end of March 2021 include:

  • Scale-up of integrated HIV services had reached the following number of sites:
         * __724__ static and __154__ outreach HIV testing sites.
         * __ 760__ (static) ART sites; __605__ of these started at least one pregnant or breastfeeding woman.
         * __699__ sites with HIV-exposed children in follow-up.
    
    • 670,567 persons were tested for HIV by a trained provider and received their results; 131,552 (20%) accessed HIV testing for the first time; 539,015 (80%) were repeat testers and 22,296 (4%) of these received confirmatory testing (after having tested positive in the past). 20,078 (3.1%) clients received a positive result for the first time.
    • A total of 104,724 people received 173,272 self-test kits; 77,033 (44%) of these were for use by the recipient and 96,239 (56%) for onward distribution to sex partners or other people.
    • 18,193 (97%) of 18,802 blood units collected were screened for (at least) HIV, hepatitis B and syphilis.
    • A cumulative total of 825 clients were referred for PrEP eligibility screening and 544 (66%) were found eligible. 277 newly started PrEP and 177 clients were retained on PrEP at the end of the quarter.
    • 155,575 (99%) of 157,743 women at ANC had their HIV status ascertained; 10,724 (7%) of these were HIV positive. 131,564 (95%) of 139,169 at maternity had their HIV status ascertained 9,387 (7%) of these were HIV positive.
    • 19,682 patients started ART this quarter; 79% were classified as asymptomatic / in WHO stage 1 and started under the “Test & Treat” policy.
    • 871,098 patients were alive and on ART by end of March 2021.2 This means that 88% of the estimated 986,671 HIV positive population was on ART. 3 ART coverage was 78% (44,960/ 57,530) for children4 and 89% (826,138 / 929,141) for adults.
    • 136,281 (95%) of viral load results from routine monitoring were <1000 copies/ml. Viral suppression rates for routine samples among children (0-14 years) and adults (15+ years) were 77% and 96%, respectively.
    • 73% of adults and 76% of children were retained alive on ART at 12 months after initiation.
    • Out of 851,998 patients on first line adult ART 817,888 (97%) had transitioned to TDF/3TC/DTG and only 4,388 (1%) were on TDF/3TC/EFV.

Data and Resources

Additional Info

Field Value
Program Area Care and Treatment
Year 2021
Author
Author Email cmkandawire@hivmw.org